Research into oral acute toxicity and genotoxicity adds another dimension to understanding blue scorpion venom.
Veterinary Medicine and Science
Selected publications. Each finding belongs to the material and experimental model studied.
SCIENCE IS A COLLABORATIVE EFFORT.
02 / THE PEOPLE & THE PARTNERSHIPS
Behind the research, a scientific team.
Grupo LifEscozul studies blue scorpion venom, its fractions and individual components to understand their biological activity and explore future applications in oncology.
Our work connects laboratory research with academic collaborations and preclinical evaluation.
Conceptual illustrations. These are published applications, not representations of granted patent status.
Conceptual product presentation.
04 / OUR PRODUCT
Meet Escozul®.
The product within the LifEscozul story.
Developed from our work with blue scorpion venom, Escozul sits alongside a continuing research program and a team dedicated to information and support.
NDC listed
Listed in the FDA’s National Drug Code Directory. Listing is not FDA approval.
Research, explained
Escozul is our product. PBK2 is a component within a specific research line. Experimental findings do not automatically establish the product’s clinical effects.
A naturally occurring mixture of biologically active molecules produced by the Cuban blue scorpion. The species appears in the scientific literature as Rhopalurus junceus, also known as Heteroctenus junceus.
Its venom contains peptides, proteins and other components. Scientists study the whole venom, separated fractions and individual molecules to understand how each interacts with biological systems—including cancer-cell models.
Whole venom→Fractions→Peptides
This is why the exact material and experimental model matter: findings about one fraction or peptide do not describe every venom-derived product.
Dr. Alexis Díaz-GarcíaDirector of Research & Development Grupo LifEscozul
Alexis is a researcher with a doctorate in Pharmaceutical Sciences and a master’s degree in Experimental Pharmacology from the University of Havana. His background also includes microbiology and postdoctoral work at the University of Chile.
His research explores the biological activity of blue scorpion venom, cancer-cell responses and molecular mechanisms. He is an author of the ion-channel review and experimental lung-cancer study featured on this page.
Our approach brings scientific research and personal support together. We investigate blue scorpion venom and its components while helping people understand our work, our product and the process of engaging with our team.
THE SCIENTIFIC SIDEResearch you can explore.
Published studies, academic collaborations and patent applications with original documents you can read.
THE HUMAN SIDEA team you can talk to.
Answers to questions, guidance through the evaluation process and ongoing communication and follow-up.
That combination—research, product information and accompaniment—defines how we work with our community.
Escozul® is Grupo LifEscozul’s product derived from blue scorpion venom. The U.S. label describes an alcohol-free homeopathic liquid taken orally, containing blue scorpion extract at a 6X homeopathic dilution and labeled for general well-being.
Its U.S. label is available through DailyMed under NDC 87019-001-01. This listing identifies the product; it is not FDA approval.
Escozul is the finished product. PBK2 is a peptide within a specific research line. The venom and fractions examined in laboratory studies are not interchangeable with the finished formulation.
Our team can explain the product information and the support services available to you.
Read original paper ↗
Read original paper ↗
Read original paper ↗
SCIENCE IS A COLLABORATIVE EFFORT.
